DENOSUMAB (Xgeva®)

Clinical Indication

Prevention of skeletal related events for myeloma patients with CKD (GFR <10ml/min)

Date of classification

May 2015

Red

Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.